AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1346172
Drug: Gestrinone (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gestrinone (2.5 mg twice a week for 3 months)
Trial: 24373681
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no physical therapy)
Trial: 24382182
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group without any treatment (CG)
Trial: 19695404
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation of glucosamine sulfate 500 mg
Trial: 19695404
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation of glucosamine sulfate 500 mg
Trial: 8732695
Drug: Perilymphatic injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perilymphatic injections of recombinant interleukin-2 (rIL-2)
Trial: 30975352
Drug: Patch group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patch group
Trial: 20697803
Drug: Celecoxib 400
RxNorm normalized name: celecoxib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 400 mg/day for 14 days
Trial: 14633547
Drug: IT morphine
RxNorm normalized name: IT-139
DrugBank: IT-139 (DB17145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IT morphine 100 microg
Trial: 14633547
Drug: IT morphine
RxNorm normalized name: IT-139
DrugBank: IT-139 (DB17145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IT morphine 200 microg
Trial: 14633547
Drug: IT morphine
RxNorm normalized name: IT-139
DrugBank: IT-139 (DB17145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IT morphine 50 microg
Trial: 14633547
Drug: IT morphine
RxNorm normalized name: IT-139
DrugBank: IT-139 (DB17145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IT morphine 0 microg
Trial: 14633547
Drug: IT morphine
RxNorm normalized name: IT-139
DrugBank: IT-139 (DB17145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IT morphine 100 microg vs 200 microg
Trial: 14633547
Drug: IT morphine
RxNorm normalized name: IT-139
DrugBank: IT-139 (DB17145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IT morphine 100 microg vs 50 microg vs 200 microg
Trial: 8393359
Drug: oral alkali
RxNorm normalized name: alkali blite pollen extract
DrugBank: Suaeda moquinii pollen (DB10953)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oral alkali therapy with sodium bicarbonate 2 mmol/kg/day
Trial: 7095559
Drug: no therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: no therapy (control group)
Trial: 31518044
Drug: Aged garlic
RxNorm normalized name: Garlic 600 MG Oral Tablet [KYOLIC AGED GARLIC EXTRACT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aged garlic extract (AGE) 2400 mg daily for 1 year
Trial: 24685998
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group (church-based health program)
Trial: 22719932
Drug: Rapid antivenom
RxNorm normalized name: Abreva Rapid Pain Relief
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid antivenom infusion (20 minute infusion)
Trial: 22719932
Drug: Slow antivenom
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow antivenom infusion (2 hour infusion)
Trial: 22719932
Drug: Rapid antivenom
RxNorm normalized name: Abreva Rapid Pain Relief
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid antivenom infusion
Trial: 22719932
Drug: Slow antivenom
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow antivenom infusion
Trial: 24525660
Drug: Escitalopram (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram (10 mg/d)
Trial: 16134010
Drug: Moderately intoxicating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderately intoxicating alcohol dose
Trial: 11939442
Drug: Diclofenac 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 0.5 mg/kg
Trial: 7137662
Drug: Midazolam (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (10 mg)
Trial: 24446238
Drug: Assist control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Assist control mode with 6 mL/kg tidal volume and constant flow 60 L/min
Trial: 24446238
Drug: Assist control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Assist control mode with 8 mL/kg tidal volume and decelerating flow 40 L/min
Trial: 22866000
Drug: Ricotta cheese
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ricotta cheese (210 g/day) plus habitual diet
Trial: 15867104
Drug: Nefazodone (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nefazodone (100 to 600 mg/d)
Trial: 15867104
Drug: CBASP (twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CBASP (twice weekly for weeks 1-4, weekly thereafter)
Trial: 12419087
Drug: Oral conjugated
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral conjugated equine estrogens (CEE) 0.625 mg daily
Trial: 12419087
Drug: Transdermal 17beta-estradiol
RxNorm normalized name: Estradiol-17beta
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal 17beta-estradiol 50 microg
Trial: 7768364
Drug: Metronidazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (20 mg/kg body wt) daily for 3 months
Trial: 2138436
Drug: loratadine 40
RxNorm normalized name: Loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: loratadine 40 mg once daily
Trial: 2138436
Drug: clemastine 1
RxNorm normalized name: clemastine 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: clemastine 1 mg twice daily
Trial: 6643055
Drug: Anthralin therapy
RxNorm normalized name: Anthralin
DrugBank: Anthralin (DB11157)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anthralin therapy
Trial: 6643055
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy with anthralin and steroid
Trial: 26402009
Drug: Supportive Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive Therapy for Cognitively Impaired Older Adults (ST‐CI)
Trial: 12047962
Drug: 5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/kg infliximab every 8 weeks (group II)
Trial: 12047962
Drug: 10 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/kg infliximab every 8 weeks (group III)
Trial: 12047962
Drug: 5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/kg infliximab (group II and III combined)
Trial: 12047962
Drug: 5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/kg infliximab (group II and III)
Trial: 12047962
Drug: 5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/kg infliximab (group I)
Trial: 9565821
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg beta-carotene/kg BW/d up to 50 kg BW, 50 mg beta-carotene/d for 12 weeks, then 10 mg beta-carotene/d for 12 weeks
Trial: 3369709
Drug: Antibiotics plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics plus kallikrein (600 units per day for 3 months)
Trial: 3369709
Drug: Antibiotics plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics plus kallikrein
Trial: 29986935
Drug: Endovascular therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular therapy (thrombectomy)
Trial: 27117004
Drug: Xylitol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xylitol (50 g in 300 ml of water)
Trial: 27117004
Drug: Erythritol (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythritol (75 g in 300 ml of water)
Trial: 27117004
Drug: Glucose (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose (75 g in 300 ml of water)
Trial: 19865105
Drug: Inosine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inosine treatment
Trial: 1912128
Drug: Melatonin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (75 mg per os)
Trial: 16362147
Drug: Alendronate 10
RxNorm normalized name: ALENDRONATE 10MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 10 mg daily (n=11)
Trial: 16362147
Drug: Alendronate 70
RxNorm normalized name: ALENDRONATE 70MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 70 mg once weekly (open-label phase)
Trial: 16362147
Drug: Placebo followed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo followed by Alendronate 70 mg once weekly (open-label phase)
Trial: 9726393
Drug: Rabeprazole 20
RxNorm normalized name: RABEprazole 20 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole 20 mg once daily for 3 weeks
Trial: 9726393
Drug: Rabeprazole 20
RxNorm normalized name: RABEprazole 20 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole 20 mg once daily for 6 weeks
Trial: 9726393
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg once daily for 3 weeks
Trial: 9726393
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg once daily for 6 weeks
Trial: 26360825
Drug: HOT meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HOT meal containing 5.82 mg total capsaicinoids
Trial: 25751199
Drug: Single-size diaphragm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-size diaphragm with acid-buffering gel
Trial: 23524437
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of melatonin (1% orabase cream formula) once daily for 20 days
Trial: 23524437
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of melatonin
Trial: 17182805
Drug: Moderate consumption
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate consumption of olive oil (25 mL/d)
Trial: 1583252
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) 200 micrograms once daily
Trial: 31076272
Drug: Oral and
RxNorm normalized name: Tridate, oral and rectal kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral and locally administered corticosteroids
Trial: 31076272
Drug: Nasal steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal steroid spray and antihistamine drugs
Trial: 24837690
Drug: Simvastatin 40
RxNorm normalized name: simvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 40 mg once a day for up to 21 days
Trial: 23009311
Drug: Glycerol-based emollient
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycerol-based emollient cream (Dexeryl, Pierre Fabre)
Trial: 18090458
Drug: Stalevo 50
RxNorm normalized name: Stalevo 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stalevo 50 (LCE50; 50/12.5/200 mg)
Trial: 18090458
Drug: Stalevo 100
RxNorm normalized name: Stalevo 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stalevo 100 (LCE100; 100/25/200 mg)
Trial: 18090458
Drug: Stalevo 150
RxNorm normalized name: Stalevo 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stalevo 150 (LCE150; 150/37.5/200 mg)
Trial: 18090458
Drug: Sinemet 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sinemet 100 (LC100; 100/25 mg)
Trial: 18090458
Drug: All treatments
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All treatments (LCE50, LCE100, LCE150, LC100)
Trial: 15096909
Drug: Cyclazocine (0.2,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclazocine (0.2, 0.4 and 0.8 mg)
Trial: 15096909
Drug: Hydromorphone (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydromorphone (5 and 15 mg)
Trial: 15096909
Drug: Cyclazocine (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclazocine (0 mg pretreatment)
Trial: 15096909
Drug: Cocaine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine (100 mg intranasal)
Trial: 6138082
Drug: Midazolam 10
RxNorm normalized name: midazolam 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 10 mg (oral)
Trial: 6138082
Drug: Midazolam 20
RxNorm normalized name: midazolam 200 mg/200 mL-D5% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 20 mg (oral)
Trial: 6138082
Drug: Midazolam 40
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Midazolam 40 mg (oral)
Trial: 6138082
Drug: Midazolam 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.15 mg kg‐1 (intravenous)
Trial: 31874050
Drug: 50,000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50,000 IU vitamin D3 pearl once weekly for 12 weeks
Trial: 27753609
Drug: No active
RxNorm normalized name: Aveeno Active Naturals
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No active treatment (arm C)
Trial: 16093267
Drug: Testosterone therapy
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone therapy (5 mg Androderm)
Trial: 10953135
Drug: 1 implant
RxNorm normalized name: LEUPROLIDE ACETATE 72 MILLIGRAM In 1 IMPLANT SUBCUTANEOUS IMPLANT [Viadur]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 implant
Trial: 10953135
Drug: 2 implants
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 implants
Trial: 1616516
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal 50 gm every hour for 8 hours (cumulative dose 150 gm)
Trial: 1616516
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal 25 gm every 2 hours for 8 hours (cumulative dose 150 gm)
Trial: 1616516
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal 12.5 gm every hour for 8 hours (cumulative dose 150 gm)
Trial: 1616516
Drug: Control phase
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control phase (no activated charcoal, only aminophylline 8 mg/kg)
Trial: 6437264
Drug: Oral sodium
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral sodium cromoglycate (200-1600 mg/24 h)
Trial: 30107641
Drug: Single-step nasal
RxNorm normalized name: PostDay One-Step
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Single-step nasal spray (SP)
Trial: 30107641
Drug: Intramuscular simulated
RxNorm normalized name: bisacodyl
DrugBank: Bisacodyl (DB09020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular simulated naloxone (IM)
Trial: 30107641
Drug: Multi-step atomized
RxNorm normalized name: PostDay One-Step
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Multi-step atomized nasal spray (AT)
Trial: 24033356
Drug: Fasudil (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fasudil (30 mg intravenous administration)
Trial: 17663619
Drug: Daily weighing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily weighing
Trial: 16105050
Drug: irbesartan 300
RxNorm normalized name: irbesartan 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: irbesartan 300 mg once daily
Trial: 16105050
Drug: irbesartan 600
RxNorm normalized name: Irbesartan
DrugBank: Irbesartan (DB01029)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: irbesartan 600 mg once daily
Trial: 16105050
Drug: irbesartan 900
RxNorm normalized name: Irbesartan
DrugBank: Irbesartan (DB01029)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: irbesartan 900 mg once daily
Trial: 10658441
Drug: Short-term treatment
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term treatment protocol (STP) with PGE1 alpha-ciclodestrina: 2-hour infusions (20 micrograms in the morning, 40 micrograms in the afternoon on the first day; 60 micrograms b.i.d. on the second day) for 2 days, repeated at weeks 4, 8, 12.
Trial: 10658441
Drug: Long-term treatment
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term treatment protocol (LTP) with PGE1 alpha-ciclodestrina: 2-hour infusions (60 micrograms PGE1 alpha-ciclodestrina, 5 days each week for 4 weeks, then twice a week for 4 weeks).
Trial: 331627
Drug: Amikacin sulfate
RxNorm normalized name: Amikacin Sulfate
DrugBank: Amikacin (DB00479)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Amikacin sulfate (15 mg./Kg.)
Trial: 331627
Drug: Amikacin sulfate
RxNorm normalized name: Amikacin Sulfate
DrugBank: Amikacin (DB00479)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Amikacin sulfate (7.5 mg./Kg.)
Trial: 27884722
Drug: Sequential anthracycline-taxane
RxNorm normalized name: methacycline
DrugBank: Metacycline (DB00931)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sequential anthracycline-taxane chemotherapy
Trial: 27884722
Drug: Epirubicin/fluorouracil/cyclophosphamid chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin/fluorouracil/cyclophosphamid chemotherapy (FEC)
Trial: 23063373
Drug: Subcutaneous immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous immunotherapy (SCIT) with Standardized Quality (SQ) 6-grass mix and rye allergen extract, 8-day up-dosing schedule to 10,000 SQ-units (6 daily injections) followed by 2 maintenance injections of 10,000 SQ-units at intervals of 2 and 4 weeks.
Trial: 11522698
Drug: Inhaled insulin
RxNorm normalized name: insulin, regular, human Inhalation Powder [Afrezza]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled insulin regimen
Trial: 11522698
Drug: Subcutaneous insulin
RxNorm normalized name: subcutaneous insulin pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous insulin regimen
Trial: 7944467
Drug: Intraarterial chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraarterial chemotherapy with MTX, ADR, and CDDP
Trial: 7944467
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose of CDDP (more than 100 mg/m2)
Trial: 7944467
Drug: Intraarterial chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraarterial chemotherapy (general)
Trial: 27655326
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) applied before plyometric exercise
Trial: 27655326
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) applied after plyometric exercise
Trial: 12081819
Drug: 30 g
RxNorm normalized name: Lancet Unilet 30 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g isolated soy protein (ISP)
Trial: 12081819
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g isolated soy protein (ISP)
Trial: 28864134
Drug: Left cardiac
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Left cardiac sympathetic denervation (LCSD) as an adjunct to guideline recommended medical therapy
Trial: 28864134
Drug: Guideline recommended
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guideline recommended medical therapy
Trial: 23725997
Drug: Concurrent stereotactic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent stereotactic radiosurgery (SRS) and bevacizumab (BVZ)
Trial: 21214392
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) using a 50 mW 660 nm GaAlAs laser, irradiated at 1.75 W/cm² for 28 seconds per point, at three points around the cryosurgical site, immediately after treatment and at 48 and 72 hours post-treatment.
Trial: 21214392
Drug: Cryosurgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cryosurgical treatment without LLLT (Non-LLLT group).
Trial: 19447369
Drug: Photodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic therapy (PDT) using a bioadhesive patch loaded with 38 mg cm(‐2) aminolevulinic acid, administered in one or two cycles.
Trial: 19447369
Drug: Photodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic therapy (PDT) using a bioadhesive patch loaded with 38 mg cm(‐2) aminolevulinic acid.
Trial: 15717704
Drug: Cisatracurium 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisatracurium 0.15 mg kg(‐1)
Trial: 15717704
Drug: Vecuronium 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium 0.1 mg kg(‐1)
Trial: 11258644
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C supplementation (1 g dose, 2 hours before exercise)